These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3621118)

  • 1. Prognostic factors in stage II endometrial carcinoma.
    Larson DM; Copeland LJ; Gallager HS; Wharton JT; Gershenson DM; Edwards CL; Malone JM; Rutledge FN
    Cancer; 1987 Sep; 60(6):1358-61. PubMed ID: 3621118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term survival in patients with para-aortic lymph node metastasis with systematic retroperitoneal lymphadenectomy followed by adjuvant chemotherapy in endometrial carcinoma.
    Hiura M; Nogawa T; Matsumoto T; Yokoyama T; Shiroyama Y; Wroblewski J
    Int J Gynecol Cancer; 2010 Aug; 20(6):1000-5. PubMed ID: 20683408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of gross myometrial invasion with endometrial cancer.
    Larson DM; Connor GP; Broste SK; Krawisz BR; Johnson KK
    Obstet Gynecol; 1996 Sep; 88(3):394-8. PubMed ID: 8752246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FIGO stage IIIC endometrial carcinoma with metastases confined to pelvic lymph nodes: analysis of treatment outcomes, prognostic variables, and failure patterns following adjuvant radiation therapy.
    Nelson G; Randall M; Sutton G; Moore D; Hurteau J; Look K
    Gynecol Oncol; 1999 Nov; 75(2):211-4. PubMed ID: 10525373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Survival, prognostic factors and modern tendencies in adjuvant treatment of diagnosed endometrial cancer patients with or without lymph node dissection].
    Ivanov I
    Akush Ginekol (Sofiia); 2009; 48 Suppl 1():3-11. PubMed ID: 20387272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphadenectomy as a prognostic marker in uterine non-endometrioid carcinoma.
    Mylonas I; Schindlbeck C
    Arch Gynecol Obstet; 2012 Jan; 285(1):207-14. PubMed ID: 21538008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of myometrial invasion and tumor free distance from uterine serosa in endometrial cancer.
    Ozbilen O; Sakarya DK; Bezircioglu I; Kasap B; Yetimalar H; Yigit S
    Asian Pac J Cancer Prev; 2015; 16(2):519-22. PubMed ID: 25684481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stage II carcinoma of the endometrium: results of therapy and prognostic factors.
    Grigsby PW; Perez CA; Camel HM; Kao MS; Galakatos AE
    Int J Radiat Oncol Biol Phys; 1985 Nov; 11(11):1915-23. PubMed ID: 4055452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors in early carcinoma of the endometrium.
    Genest P; Drouin P; Gerig L; Girard A; Stewart D; Prefontaine M
    Am J Clin Oncol; 1987 Feb; 10(1):71-7. PubMed ID: 3825996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Stage I and II endometrial adenocarcinomas. Prognostic value of lymph node invasion].
    Descamps P; Calais G; Vitu L; Body G; Lansac J; Le Floch O
    J Gynecol Obstet Biol Reprod (Paris); 1991; 20(2):223-9. PubMed ID: 2071867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Para-aortic node biopsy in cervical and endometrial cancers: does it affect survival?
    Blythe JG; Hodel KA; Wahl TP; Baglan RJ; Lee FA; Zivnuska FR
    Am J Obstet Gynecol; 1986 Aug; 155(2):306-14. PubMed ID: 3740147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraoperative evaluation of depth of myometrial invasion in stage I endometrial adenocarcinoma.
    Doering DL; Barnhill DR; Weiser EB; Burke TW; Woodward JE; Park RC
    Obstet Gynecol; 1989 Dec; 74(6):930-3. PubMed ID: 2586959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of interval from preoperative irradiation to hysterectomy for endometrial carcinoma.
    Komaki R; Cox JD; Hartz AJ; Wilson JF; Mattingly R
    Cancer; 1986 Aug; 58(4):873-9. PubMed ID: 3719554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stage II endometrial carcinoma: prognostic factors and the results of treatment.
    Andersen ES
    Gynecol Oncol; 1990 Aug; 38(2):220-3. PubMed ID: 2387540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of malignant cervical cytology in patients with endometrial cancer.
    Larson DM; Johnson KK; Reyes CN; Broste SK
    Obstet Gynecol; 1994 Sep; 84(3):399-403. PubMed ID: 8058238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
    Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
    Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A clinicopathologic evaluation of "depth" in cases of endometrial adenocarcinoma].
    Sakamoto A; Hirai Y; Yamauchi K; Masubuchi K; Hasumi K
    Gan No Rinsho; 1990 May; 36(6):711-4. PubMed ID: 2348558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Metastatic mechanisms of uterine malignancies and therapeutic consequences].
    Lax SF; Tamussino KF; Lang PF
    Pathologe; 2016 Nov; 37(6):549-556. PubMed ID: 27757531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [An evaluation of para-aortic and pelvic lymph node metastases in patients with endometrial carcinoma].
    Tsukamoto N; Matsukuma K; Saito T; Matsuyama T; Kamura T; Kaku T; Suenaga T
    Gan No Rinsho; 1987 Oct; 33(13):1705-11. PubMed ID: 3694803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stage II endometrial carcinoma. Results and complications of a combined radiotherapeutic-surgical approach.
    Larson DM; Copeland LJ; Gallager HS; Kong JP; Wharton JT; Stringer CA
    Cancer; 1988 Apr; 61(8):1528-34. PubMed ID: 3349418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.